Targeting CRAC channels in inflammatory bowel disease

Area of Science:

• Gastroenterology
• Immunology
• Cellular Biology

Background:

• Inflammatory bowel disease (IBD) involves immune system dysregulation in the gastrointestinal tract.
• Specific immune cell populations, including T cells and innate lymphoid cells (ILCs), are implicated in IBD pathogenesis.
• Store-operated calcium entry (SOCE) is a critical signaling pathway in immune cell function.

Purpose of the Study:

• To investigate the role of SOCE in immune cell-mediated inflammation in IBD.
• To evaluate the therapeutic potential of pharmacological SOCE inhibition in IBD models.

Main Methods:

• Analysis of immune cell populations in the lamina propria (LP) of IBD patients.
• Pharmacological inhibition of SOCE in isolated immune cells.
• Assessment of IBD severity and weight loss in a murine IBD model following systemic SOCE inhibition.

Main Results:

• Enrichment of CD4+ effector T cells, IFNγ-producing CD8+ T cells, regulatory T cells, and ILCs was observed in the LP of IBD patients.
• Pharmacological SOCE inhibition decreased cytokine production in these immune cells.
• Systemic SOCE inhibition ameliorated IBD severity and reduced weight loss in a murine model.

Conclusions:

• SOCE plays a significant role in the inflammatory responses of key immune cells implicated in IBD.
• Pharmacological inhibition of SOCE demonstrates therapeutic potential for managing IBD.
• Targeting SOCE represents a promising strategy for future IBD therapies.